Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in Curr Opin Immunol Retrieve available abstracts of 55 articles: HTML format

Single Articles

May 2026
1. ARACHCHILLAGE DJ, Efthymiou M, Cohen H
   The role of different aPL subpopulations in the lupus anticoagulant phenomenon.
   Curr Opin Immunol. 2026;100:102784.
   PubMed     Abstract available
   
   
   April 2026
2. SURESH SC, Furie R, Narain S
   Outcome measures in systemic lupus erythematosus.
   Curr Opin Immunol. 2026;100:102782.
   PubMed     Abstract available
   
   
   
3. SEVIM E, Erton ZB, Erkan D
   Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
   Curr Opin Immunol. 2026;100:102770.
   PubMed     Abstract available
   
   
   
4. FUJIEDA Y, Amengual O, Meroni PL, Atsumi T, et al
   Hot topics in the antiphospholipid syndrome.
   Curr Opin Immunol. 2026;100:102775.
   PubMed     Abstract available
   
   
   
5. KIROU KA, Kirou RA, Flouda S
   New developments and future directions in the management of systemic lupus erythematosus.
   Curr Opin Immunol. 2026;100:102774.
   PubMed     Abstract available
   
   
   
6. MARTINEZ T, Grand Z, Garcia S, Rockwell M, et al
   A global perspective on autoimmunity and immunodeficiency: exploring geoepidemiology trends.
   Curr Opin Immunol. 2026;100:102773.
   PubMed     Abstract available
   
   
   
7. KUMAR S, Ponzar N, Pozzi N
   beta(2)-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms.
   Curr Opin Immunol. 2026;100:102771.
   PubMed     Abstract available
   
   
   
8. KIRINO Y, Takeno M
   A critical look at animal and cellular models in autoinflammatory diseases.
   Curr Opin Immunol. 2026;99:102719.
   PubMed     Abstract available
   
   
   March 2026
9. MATHEOUD D, Akbar I, Hercun J, Stratton JA, et al
   A liver-mitochondria-immune axis in Parkinson's disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson's disease.
   Curr Opin Immunol. 2026;100:102761.
   PubMed     Abstract available
   
   
   
10. YALAVARTHI S, NaveenKumar SK, Knight JS
    Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102768.
    PubMed     Abstract available
    
    
    
11. RENAUDINEAU Y, Brooks W
    P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectives.
    Curr Opin Immunol. 2026;100:102752.
    PubMed     Abstract available
    
    
    
12. GROSSI C, Buckle II, McDonnell TC
    Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?
    Curr Opin Immunol. 2026;100:102748.
    PubMed     Abstract available
    
    
    February 2026
13. JULIAN VELASCO-LANCHEROS O, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, et al
    Mpox virus immunology: exploring links to autoimmune diseases.
    Curr Opin Immunol. 2026;99:102744.
    PubMed     Abstract available
    
    
    
14. ALTINTAS A, Bulus E
    Multiple sclerosis: a disease or a syndrome?
    Curr Opin Immunol. 2026;99:102736.
    PubMed     Abstract available
    
    
    
15. MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
    Primary angiitis of the central nervous system.
    Curr Opin Immunol. 2026;98:102691.
    PubMed     Abstract available
    
    
    January 2026
16. ELSAGHIR A, Witte T
    New autoantibodies in Sjogren's disease.
    Curr Opin Immunol. 2026;99:102722.
    PubMed     Abstract available
    
    
    December 2025
17. YANG T, Goudarzi N, Kroese FGM, Mariette X, et al
    Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjogren's disease.
    Curr Opin Immunol. 2025;98:102707.
    PubMed     Abstract available
    
    
    November 2025
18. SWEENEY N, Atisha-Fregoso Y, Pozovskiy R, Higdon L, et al
    Can we cure autoimmunity?
    Curr Opin Immunol. 2025;98:102684.
    PubMed     Abstract available
    
    
    October 2025
19. ROJAS M, Acosta-Ampudia Y, Monsalve DM, Rami?rez-Santana C, et al
    Autoimmunity, epitope analysis, and molecular mimicry.
    Curr Opin Immunol. 2025;97:102681.
    PubMed     Abstract available
    
    
    
20. CLEMENT TL, Cohen PL
    Can we cure lupus?
    Curr Opin Immunol. 2025;96:102640.
    PubMed     Abstract available
    
    
    
21. MAHARAJ S, Chang C
    Can juvenile idiopathic arthritis be cured?
    Curr Opin Immunol. 2025;96:102632.
    PubMed     Abstract available
    
    
    
22. SULLIVAN JK, Kwun A, Jorgensen TN
    Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models.
    Curr Opin Immunol. 2025;96:102631.
    PubMed     Abstract available
    
    
    
23. FREE ME, Ciavatta DJ, Falk RJ
    Can we cure vasculitis?
    Curr Opin Immunol. 2025;96:102618.
    PubMed     Abstract available
    
    
    September 2025
24. CLAVARINO G, Vigne J, Meuleman MS, Amen A, et al
    Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions.
    Curr Opin Immunol. 2025;97:102655.
    PubMed     Abstract available
    
    
    August 2025
25. MOSELEY CE, Sabatino JJ Jr, Zamvil SS
    B-cell antigen presentation in central nervous system autoimmunity.
    Curr Opin Immunol. 2025;96:102647.
    PubMed     Abstract available
    
    
    
26. HU Z, Zhao M
    B cell-targeted therapies in autoimmune skin disease: current advances and challenges.
    Curr Opin Immunol. 2025;96:102643.
    PubMed     Abstract available
    
    
    
27. DRAGON DUREY MA, Hamidi H, Darnige L
    Complement in antiphospholipid syndrome, time to target?
    Curr Opin Immunol. 2025;96:102628.
    PubMed     Abstract available
    
    
    
28. MERONI PL, Capobianco E, Tedesco F
    Can we cure antiphospholipid syndrome?
    Curr Opin Immunol. 2025;96:102610.
    PubMed     Abstract available
    
    
    
29. CETIN GEDIK K, Casares-Marfil D, Demirkaya E, Sawalha AH, et al
    The role of epigenetic modifications in systemic autoinflammatory diseases.
    Curr Opin Immunol. 2025;95:102599.
    PubMed     Abstract available
    
    
    
30. XU C, Shen Y, Wang Q, Zhu H, et al
    Immunotherapy for pemphigus and bullous pemphigoid.
    Curr Opin Immunol. 2025;95:102591.
    PubMed     Abstract available
    
    
    
31. LIU S, Lu Q
    Can we cure bullous skin diseases?
    Curr Opin Immunol. 2025;95:102589.
    PubMed     Abstract available
    
    
    
32. OKAZAKI K, Ikeura T, Uchida K
    'Can we cure IgG4-related diseases?'.
    Curr Opin Immunol. 2025;95:102564.
    PubMed     Abstract available
    
    
    July 2025
33. LIN SL, Carroll MC
    Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus.
    Curr Opin Immunol. 2025;96:102608.
    PubMed     Abstract available
    
    
    
34. LONGHI MS, Zhang L, Mieli-Vergani G, Vergani D, et al
    Can we cure autoimmune hepatitis?
    Curr Opin Immunol. 2025;96:102609.
    PubMed     Abstract available
    
    
    
35. DEI ZOTTI F, Hudson KE
    Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.
    Curr Opin Immunol. 2025;95:102604.
    PubMed     Abstract available
    
    
    
36. FAN S, Pruss H
    Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
    Curr Opin Immunol. 2025;95:102594.
    PubMed     Abstract available
    
    
    
37. XU Y, Yi X, Li C, Chen J, et al
    CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
    Curr Opin Immunol. 2025;95:102600.
    PubMed     Abstract available
    
    
    June 2025
38. NIE W, Yang X, Ma M, Xu X, et al
    Chimeric antigen receptor T cell therapy for autoimmune diseases.
    Curr Opin Immunol. 2025;95:102596.
    PubMed     Abstract available
    
    
    
39. DAI M, Mei B, Zheng F, Ballestar E, et al
    Sex hormones and epigenetic dysregulation in autoimmune disease.
    Curr Opin Immunol. 2025;95:102595.
    PubMed     Abstract available
    
    
    
40. ZHOU W, Zhang B, Zhao M, Lu Q, et al
    Epigenetics: the link between environmental exposures and autoimmune diseases.
    Curr Opin Immunol. 2025;95:102592.
    PubMed     Abstract available
    
    
    
41. MAUDES E, Planaguma J, Weber MS, Dalmau J, et al
    Animal models of autoimmune encephalitis.
    Curr Opin Immunol. 2025;95:102579.
    PubMed     Abstract available
    
    
    
42. GUVENC F, Danska JS
    The intestinal microbiome in type 1 diabetes: bridging early childhood exposures with translational advances.
    Curr Opin Immunol. 2025;94:102553.
    PubMed     Abstract available
    
    
    May 2025
43. CHEN J, Wang X
    Epigenetic regulation of B cell response in autoimmune diseases.
    Curr Opin Immunol. 2025;95:102582.
    PubMed     Abstract available
    
    
    
44. LE PANSE R
    Is there a path to cure myasthenia gravis?
    Curr Opin Immunol. 2025;95:102577.
    PubMed     Abstract available
    
    
    
45. KOLEV M, Kremer AE, Sokollik C, Gershwin ME, et al
    Unmet needs in autoimmune liver diseases.
    Curr Opin Immunol. 2025;95:102565.
    PubMed     Abstract available
    
    
    April 2025
46. TAYLOR H, Uhlig HH, Powrie F
    Autoimmunity in inflammatory bowel disease: a holobiont perspective.
    Curr Opin Immunol. 2025;94:102557.
    PubMed     Abstract available
    
    
    
47. SUN Y, Zhang Z, Jia K, Liu H, et al
    Autoimmune-related adverse events induced by immune checkpoint inhibitors.
    Curr Opin Immunol. 2025;94:102556.
    PubMed     Abstract available
    
    
    
48. SAVVIDES CS, James EA, Buckner JH
    Rheumatoid arthritis - the role of T cells in this complex systemic autoimmune disease.
    Curr Opin Immunol. 2025;94:102555.
    PubMed     Abstract available
    
    
    
49. WRIGHT RC, Campbell DJ, Levings MK
    Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity.
    Curr Opin Immunol. 2025;94:102554.
    PubMed     Abstract available
    
    
    
50. LOVELL CD, Anguera MC
    More X's, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity.
    Curr Opin Immunol. 2025;93:102543.
    PubMed     Abstract available
    
    
    
51. KRONENBERG M, Riffelmacher T
    Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases.
    Curr Opin Immunol. 2025;93:102542.
    PubMed     Abstract available
    
    
    
52. SOWERBY JM, Rao DA
    T cell-B cell interactions in human autoimmune diseases.
    Curr Opin Immunol. 2025;93:102539.
    PubMed     Abstract available
    
    
    January 2025
53. HAO K, Marshak-Rothstein A
    Nucleic acid triggers of autoimmunity and autoinflammation.
    Curr Opin Immunol. 2025;93:102535.
    PubMed     Abstract available
    
    
    December 2024
54. HARM J, Fan YT, Brenner D
    Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.
    Curr Opin Immunol. 2024;92:102511.
    PubMed     Abstract available
    
    
    September 2024
55. HAMERMAN JA, Barton GM
    The path ahead for understanding Toll-like receptors-driven systemic autoimmunity.
    Curr Opin Immunol. 2024;91:102482.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum